Skip to main content
Veterinary Medicines

Carpcoat 8 mg film-coated tablets for dogs

Authorised
  • Carprofen

Product identification

Medicine name:
Carpcoat 8 mg film-coated tablets for dogs
Carpcoat, 8 mg, plėvele dengtos tabletės šunims
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    8.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • (ID7) 70 Film-coated tablet: Box (board) with 7 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID3) 30 Film-coated tablet: Box (board) with 3 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID2) 20 Film-coated tablet: Box (board) with 2 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID5) 50 Film-coated tablet: Box (board) with 5 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID12) 250 Film-coated tablet: Box (board) with 25 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID11) 120 Film-coated tablet: Box (board) with 12 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID10) 100 Film-coated tablet: Box (board) with 10 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID8) 80 Film-coated tablet: Box (board) with 8 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID4) 40 Film-coated tablet: Box (board) with 4 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID6) 60 Film-coated tablet: Box (board) with 6 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID9) 90 Film-coated tablet: Box (board) with 9 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID1) 10 Film-coated tablet: Box (board) with 1 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) with 10 Film-coated tablet, closed with Foil (aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Lelypharma B.V.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/25/2912/001-012
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0351/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 2/12/2025